Breaking News
Harvard University is being paid off to publish fake health studies by Big Food
Border Collies at work
38% of US debt is up for refinancing in the next 18 months
America's Second-Richest Elected Official Is Acting Like He Wants to Be President
Top Tech News
'Cyborg 1.0': World's First Robocop Debuts With Facial Recognition And 360° Camera Visio
The Immense Complexity of a Brain is Mapped in 3D for the First Time:
SpaceX, Palantir and Anduril Partnership Competing for the US Golden Dome Missile Defense Contracts
US government announces it has achieved ability to 'manipulate space and time' with new tech
Scientists reach pivotal breakthrough in quest for limitless energy:
Kawasaki CORLEO Walks Like a Robot, Rides Like a Bike!
World's Smallest Pacemaker is Made for Newborns, Activated by Light, and Requires No Surgery
Barrel-rotor flying car prototype begins flight testing
Coin-sized nuclear 3V battery with 50-year lifespan enters mass production
BREAKTHROUGH Testing Soon for Starship's Point-to-Point Flights: The Future of Transportation
Flourescent biotechnology for high lighting solid cancer for more complete surgical removal
.... On Target Laboratories LLC is working to advance its revolutionary fluorescent imaging technology that could help surgeons pinpoint and remove more cancerous tissues than has ever been possible while preserving more healthy tissue for patients.
Headquartered at Purdue Research Park of West Lafayette, the company is developing a series of molecules, which, when administered intravenously, show promise in targeting many types of cancer cells, said Dr. Sumith Kularatne, On Target's vice president of research and development.
"In addition to our current U.S. patents, we have 11 more either filed or pending in the U.S.," Kularatne said. "We have another 33 patents pending worldwide. These patents are very important in helping us move our discoveries to the public where they can help people."